Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors.
about
The future role of personalized medicine in the treatment of glioblastoma multiformeUnarmed, tumor-specific monoclonal antibody effectively treats brain tumorsImmunotherapeutic strategies for malignant glioma.Immunotherapy of malignant brain tumors.Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study.Combating immunosuppression in gliomaTumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patientsCancer immunoediting in malignant glioma.Novel vaccines for glioblastoma: clinical update and perspective.Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro.Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma.
P2860
Q28391635-45EEFED2-4856-41D2-9C1F-14B9E564499BQ35162055-B296CF9C-3105-4D13-9654-A87102D3FB02Q35778576-817F68D1-0819-4F1A-87F7-56BAB021C99BQ36162929-2AD77893-5B8F-4644-B66E-DBF04274AFCDQ36695932-BE7DE2D1-5060-4979-B898-3DF52EA14852Q37179415-592AE453-8407-4495-BD77-7A54ADB0D9D1Q37186248-37C4FE86-5851-4FB7-901F-296975F58DEDQ37475929-4834B9B9-0CC5-466B-A0FF-4E3DA8BA8B68Q37986999-D415A86A-C3A2-4529-9429-96850D3E24ABQ39043417-82D7EE43-5DAD-4A39-95B4-CD031EA61F1DQ41264607-8A01F4F6-81FB-48D9-B586-4A817B2EDA88Q42112527-44335F75-A5A8-49AC-A63B-A11CD92903CE
P2860
Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Inability of mitogen-activated ...... inity interleukin 2 receptors.
@ast
Inability of mitogen-activated ...... inity interleukin 2 receptors.
@en
Inability of mitogen-activated ...... inity interleukin 2 receptors.
@nl
type
label
Inability of mitogen-activated ...... inity interleukin 2 receptors.
@ast
Inability of mitogen-activated ...... inity interleukin 2 receptors.
@en
Inability of mitogen-activated ...... inity interleukin 2 receptors.
@nl
prefLabel
Inability of mitogen-activated ...... inity interleukin 2 receptors.
@ast
Inability of mitogen-activated ...... inity interleukin 2 receptors.
@en
Inability of mitogen-activated ...... inity interleukin 2 receptors.
@nl
P2093
P2860
P356
P1476
Inability of mitogen-activated ...... inity interleukin 2 receptors.
@en
P2093
L H Elliott
T L Roszman
W H Brooks
P2860
P356
10.1172/JCI114719
P407
P577
1990-07-01T00:00:00Z